Data / Form D filings / Enobia Pharma Corp
Enobia Pharma Corp: Form D filings
Enobia Pharma Corp, a biotechnology company in Montreal, Quebec, Canada, filed 4 Form D notices with the SEC between 2009 and 2011. The latest, on August 24, 2011, reports $20 million sold of a $40 million offering to 3 investors.
Find out what Enobia Pharma Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2901 RACHEL ST., SUITE 23, Montreal, Quebec, Canada, H1W 4
- Phone
- (514) 596-2901
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2007
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1412621
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 24, 2011 | New notice | $40,000,000 | $20,000,000 | $20,000,000 | 3 | Aug 9, 2011 | sec.gov |
| Apr 1, 2011 | New notice | $46,969,070 | $15,000,000 | $31,969,070 | 7 | Mar 21, 2011 | sec.gov |
| Dec 13, 2010 | Amendment | $50,000,000 | $50,000,000 | $0 | 8 | Aug 5, 2009 | sec.gov |
| Aug 28, 2009 | New notice | $50,000,000 | $15,000,000 | $35,000,000 | 8 | Aug 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas L. Schuetz | Director | |
| Luc L. Mainville | Director | |
| Richard L. Meadows | Director | |
| Frederic L. Price | Director | |
| Jonathan L. Silverstein | Director | |
| Jeffrey Mack | Executive Officer | |
| David L. Bonita | Director | |
| Robert Heft | Executive Officer, Director | |
| Eric L. Trachtenberg | Executive Officer |
Every Form D from the week of Aug 22, 2011 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Enobia Pharma Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.